EMILY BROWN: Open Payments
NPI 1538861547 · BYESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 57 payments from 12 companies in 2025. Trend: 2023 $45 · 2024 $337 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $208 |
| ABBVIE INC. | 26 | $158 |
| AstraZeneca Pharmaceuticals LP | 4 | $156 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| Corcept Therapeutics | 1 | $26 |
| Amgen Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, AIRSUPRA, Kerendia, Auvelity, REXULTI, Korlym, Symbravo.
Industry payments across OH — which companies pay providers there.
